Final Flashcards

(137 cards)

1
Q

Neurotypical Behaviour

A
  • Dependent on development of the frontal lobe.
    • Age related improvement in memory and attention
      ○ Executive functions: abilities assigned to the frontal lobe.
      § Following directions
      § Waiting
      § Following rules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diagnosis of ADHD

Timeline

A

Symptoms must have occurred over six months onset < 12 years old.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Inattentive Type

A

a. Often distracted by external stimuli.
b. Has problems staying focused
c. Does not seem to listen when spoken to.
d. Does not follow through on instructions
e. Has problems organizing tasks & work
f. Avoids or dislikes tasks requiring sustained mental effort.
g. Often loses things
h. Doesn’t pay attention to details, careless mistakes.
i. Forgets daily tasks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Intro of ADHD

Who, what

A
  • Classified as a developmental disorder by the DSM5.
    ○ Present in children, cannot be developed in adulthood.
    • Persistent pattern of inattention and/or hyperactivity - impulsivity.
      Must be clinically significant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hyperactive/impuslive Type

A

a. Fidgets, taps hands, squirms
b. Unable to stay seated
c. Runs or climbs inappropriately
d. Unable to play or do activities quietly
e. Always ‘on the go’
f. Talks too much
g. Interrupts others
h. Difficulty waiting turn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Combined Type

A

6-9 symptoms from type 1 and 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Key Features of ADHD

A
  • Disorder must appear in multiple settings
    ○ Not limited to one place (school, etc)
    • Context matters
      ○ Signs of disorder may be minimal or absent when under close supervision.
    • Tend to create other problems in child life.
      ○ Social rejection
      No difference in IQ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Prevelance of ADHD

A
  • approx 7.6%
    • 3:1 male to female
    • Symptoms gradually reduce across life span.
    • Present worldwide but more common in north America.
      Importance of Culture:
    • DSM5 is largely based on elementary school-aged North American boys
    • In other places, it is only diagnosable in specific contexts.
      ○ Children don’t go to school (hunter - gatherer children?)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Comorbidity of ADHD

A
  • 1/3 of children are only diagnosed with ADHD.
    • 30%-60% also have autistic traits, common neurobiology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Genetics of ADHD

A
  • High genetic relation
    • Elevated in first degree biological relatives of individuals with ADHD
      ○ Siblings, parents
    • Etiology is 80% genetic, one of the most heritable disorders.
    • Strong overlap with genes of Autism Spectrum Disorder
    • No evidence to point towards what exact genes are the cause.
      ○ Maybe D4 dopamine receptor.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Environmental/Developmental Risk Factors

ADHD

A
  • Evidence for gene-environment interactions
    • Children with specific mutation in the dopamine reuptake transporter (DAT1) are more likely to exhibit symptoms of ADHD if their mothers smoked during pregnancy.
    • Perinatal Hypoxia, temporary shortage of oxygen during birth.
    • Not evidence it is caused by food coloring, preservatives or sugar
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Marshmellow Test

Behaviour During Neuropsychological Tests:

A
  • Children with ADHD are less likely to wait for second one
    ○ Don’t respond to reward based reinforcement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

‘Go, No-Go’ Task

Behaviour During Neuropsychological Tests:

A
  • Untreated people usually make more errors, enhanced motor impulsivity
    • Motor Impulsivity: controlling movements (commission, omission)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Iowa Gambling Task

Behaviour During Neuropsychological Tests:

A
  • People with ADHD make risker choices.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Behavioural Markers of ADHD:

rewards

A
  • Rewards have less influence
    • Impairments to inhibitory control
      *executive function or reward function system issues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Brain Areas Impacted

ASD

A
  • PFC
    • Parietal Cortex
    • Deep into brain
      Basal ganglia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Default Mode Network

A
  • Group of brain regions that become active when mind is at rest or day dreaming, stops when focused.
    In adhd, the DMN doesn’t deactivate which impacts executive control leading to distractibility.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Altering Network

A

Telling the person to pay attention.
- Weaker in those with adhd
Frontal Cortex, parietal cortex, Thalamus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Frontostriatal Circuit:

A

Motivationally relevant, but still benefits survival
- Basil ganglia, nucleus accumbens, cingulate cortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Treatment of ADHD

medication type and name

A
  • Psychostimulants are effective in 70-90% of cases.
    ○ Been in regular use in 1970s, approved 1960.
    • Most popular drugs are Methylphenidate (Ritalin/Concerta), Amphetamine (Adderall), and d-amphetamine (Dexedrine).
      *can cause appetite suppression and increased BP if no taken properly.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How do they work?

ADHD meds

A
  • Dopamine transporter normal moves the unbound dopamine from synapse to sending neuron (recycled).
    Ritalin blocks the transporter which causes a dopamine buildup in synapse.
    Increased Dopamine and Norepinpjrine = increased focus
    Not specific to PFC
    Need to find the correct level for proper functioning (alert).
    Dopamine and norepinephrine.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Intro ASD

A
  • Neurological and developmental disorder beginning in early childhood (under 2), lasting through persons entire life.
    • Affects how someone acts & interacts with others, communicates and learns.
    • Considered a spectrum as people with ASD have a range of symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Autism Spectrum:

A
  • Before DSM5
    ○ People on extreme end were diagnosed with autistic disorder (lower functioning)
    ○ Those who were higher functioning were diagnosed with Asperger’s Syndrome.
    ○ Aspergers as change to Autism Spectrum Disorder and has assigned numerical grafe
    § 1-3(a lot of support)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Clinical Description ASD

A
  • Parents report normal development until 12 months, then a startling decline in function.
    1. Impaired Communication:
      - Nearly always have problems or delays
      ○ As severe as never having language, to minor delays
      a. Echolalia: repeating the speech and intonation of others (melodic nature)
      i. Doesn’t respond to question, repeats questions
      ii. Children can also have an odd combination of abilities
      1) Knowing alphabet but not their own name
      2) Overly literal understanding of language,
    2. Impaired social interaction
      a. Eye contact difficulty, trouble ending conversations
      b. What is normal?
      i. Social cognition: as kids age, they learn through observation (social skills).
      1) How you think about yourself and your social world
      a) People have different feelings, unique
      2) Knowledge of perception, ideas, and intentions of others.
      3) First word reflects the world around them
      4) Learning what is important (people vs objects)
      a) Low functioning kids do not have social cognition
      b) High functioning kids are highly social.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Social interactions ASD
- Affective social competence ○ Ability to experience , send motional messages and read others' emotional signals § Lower functioning kids often are on the lower end of recognizing emotions of other people § Higher functioning kids lack actual sense or feeling of emotion, robotic § Males have less compared to females 3. Restricted Behaviour a. Exhibit repetitive, pointless behaviours (stereotypies) i. Stimming - rocking, hand flapping, yelling, self injurious b. Associated with intense preference for status quo, routines i. Liking things to stay the same c. Ritualistic behaviours are apparent, lining up blocks in specific order
25
Prevence of ASD
- 1 in 50 youth age 1-17 diagnosed - 1 in 32 males - 1 in 125 females - 53.7% diagnosed by age 5 - Some geographic differences, ability to diagnose Male to female ratio is always the same ## Footnote 2%
26
Autism and Vaccines
- Not correlated - Time bound observational affect ○ Parents want to know why their kids are showing symptoms shortly after getting vaccinated
27
Autism and Tylenol
- No correlated - Pregnant women are told to take Tylenol ○ Infections, fevers
28
# green eggs embarrass gray salt Etiology of Autism
- Genetic susceptibility ○ Epigenetics ○ Environment (smoking, drugs) ○ Gene mutations Sex-linked modifiers
29
Genetics - ASD
- Concordance rates (having the same condition), monozygotic - 36-91%, dizygotic - 0-5% Genes involved in intellectual disability,..
30
# most gay guys smell insanely lovely Environmental Risk Factors: | ASD
Maternal Diet: - Loss of fatty acids (fish), affects microbiome, immune response ○ Gilal cells ○ Gut bacteria Folic Acid Status: - Low levels can cause risk Maternal Smoking: - Exposure to alcohol or other drugs during pregnancy Maternal Infection: - Immune activation Maternal Education Level: - Relates to life environment (poverty), etc ○ Exposure to heavy metals, pollutants Advanced Maternal and Paternal Age: Older parents
31
Brain Overgrowth | Neuroscience + Autism:
a. No longer views as a focal impairment, whole brain affected b. Resulting as brain reorganization belonging in early development i. Early brain overgrowth 1) Brain is bigger, failure of synaptic pruning (killing off unneeded brain cells ) a) underconnectivity in frontal and occipital regions c. Morphological abnormalities
32
Microbiome | Neuroscience + Autism:
ut microbiota: i. Microorganisms, bacteria, viruses, protozoa, fungi, that are present in gastrointestinal tract a. Gut-brain axis: i. Microbiome can influence brain function, potentially affecting behaviours and symptoms associated with autism 1) Signals to brain directly and indirectly (immune system) ii. People with autism have a disrupted axis 1) Dysregulation, disturbances a) Increased microglia activation, elevated proinflammatory cytokines b) Increased prevalence of gastrointestinal disorders iii. Microbiota seem to be the intersection between genes and the environment 1) Depends on genetics, and shaped by environment
33
Extreme Male Brain Theory | Neuroscience + Autism:
imon Baron-Cohen i. Autism is an exaggerated male phenotype(traits) 1) Rules, patterns Prenatal Testosterone: - Psychological traits are correlated with prenatal testosterone. ○ Eye contact Young boys make less eye contact than females
34
Prenatal Testosterone and Autism:
Biological mechanism may be elevated prenatal androgen exposure especially testosterone during brain development.
35
The Mirror Neuron System:
- Discovered while looking at motor cells (within cortex) - May provide neurobiological basis for social cognition. ○ Knowledge of perceptions, ideas, and intention of others - absent for people on autism spectrum. Mirror Neurons: - Fire when individual performs a certain action, or when they observe the action being performed by someone else. ○ Could represent observational learning - Can be found in variety of places, throughout the cortex. - Respond to the understanding of an action. - Found inside the cingulate cortex, and insula ○ Motivation, emotion, empathy
36
Do individuals with ASD have a dysfunctional Mirror Neuron system?
- Kids with ASD show reduced activity (less firing) in frontal MNS. Correlated with severity of disorder.
37
Autism: Current Therapeutic Advances:
- Pharmacotherapy available - Behavioural-based therapies - Applied Behaviour Analysis (ABA) ○ Emphasize play, social interaction, and communication initiation - 'natural consequences' are the reward § Controversial: teaches kids to go against their natural brain functioning.
38
Schizophrenia
- Psychotic disorder ○ Psychosis - means a loss of contact with reality. - Schizophrenia impacts 1/100 across North America
39
Myths about SZ
1. People who have Schizophrenia are violent and dangerous: a. Those being treated are not more violent that others. b. They are a greater risk to themselves. 2. People who have schizophrenia have multiple personalities: a. Not the same as DID 3. People who have schizophrenia have multiple personalities: a. Schizophrenia is characterized mostly by auditory hallucinations.
40
Characteristics of Schizophrenia:
1. Positive Symptoms: go beyond normally occurring experiences. a. Hallucinations (most common) b. Delusions (irrational beliefs or paranoia, misrepresenting reality). 2. Negative Symptoms: characterized by a deficit or absence of normal behaviour. a. Apathy, limited thought/speech, emotional and social withdrawal 3. Cognitive Symptoms: erratic changed in speech, motor behaviour, and emotions. a. Disorganized speech, inappropriate emotional reactions.
41
Diagnostic Criteria - SZ
- Must have one of: ○ Delusions ○ Hallucinations ○ Disorganized speech - Diminished level of function - Long-lasting symptoms - Not due to drugs or other medical conditions.
42
Development - SZ
- Schizophrenia is usually diagnosed in late adolescence or early childhood. ○ Often when people are about to gain experience(epigenetics). ○ Lag of 1-2 years between onset of symptoms and diagnosis. - 85% of people experience experience subdued symptoms for about 1-2 years. *idea of reference: everything is out to get you*
43
Development and Prognosis - SZ
- 78% of people go through a pattern of relapse and recovery. - Remission can be possible ○ Good social adjustment prior to onset (family, peer groups) ○ Low proportion of negative symptoms ○ Good social support for patients. - Symptoms mat decrease with age
44
Etiology - Genetics - SZ
- Clear evidence for genetic link ○ Risk changes depending on who has a diagnosis in the family. - If it was 100% caused by genetics, you'd expect 50% of fraternal twins have schizophrenia.
45
Etiology - Perinatal Factors - SZ
- Evidence that problems before and shortly after birth can increase risk. ○ Two hit hypothesis - genetics, environment - Fetal exposure to influenza and other viruses can cause damage to the fetuses brain causes symptoms later in life. ○ Toxoplasmosis gondii - Pregnancy and delivery complications are correlated to development. ○ Loss of oxygen during delivery, maternal nutrition (first 3 months)
46
Anatomical Basis of Schizophrenia:
- People with schizophrenia have enlarged lateral ventricles ○ Ventricles are empty space, indication of loss of cells § Atrophy or miss-development □ Cause and consequence § Empty space is filled with CSF - Enlarged ventricles are in inherited risk factor, present in those with schizophrenia and those without. - Several subtle microscopic pathologies have been found. - Post-mortem brains from people with schizophrenia have less dendritic spine density in the PFC. ○ Reduced surface area and density ○ Dendritic spines are located on dendrites, each have post synaptic terminals § Gliosis - glial cell - PFC, striatum and hippocampus are most impacted.
47
Hippocampus - SZ
- Those with SZ how reduced hippocampus size. ○ Due to degradation, decreases over time due to a loss in hippocampus cells. - Degree of degradation is correlated with illness severity ○ Worse symptoms - smaller volume. Disorganized neurons in hippocampus in SZ brains, leading to cell loss.
48
Antipsychotic Drugs: | name and how it helps people - sz
- Chlorpromazine / Thorazine discovery 1950s. ○ First generation antipsychotic - Was used as an anesthetic prior but had very good success given to psychotic patients. ○ Could return to normal life. - People began to have increased tolerances which led to higher doses and health issues. - Drugs could reduce psychotic symptoms without excessive sedation ○ Allowed patients to resume normal life and to find understand the root cause of psychosis
49
How Do Antipsychotics Work
- Block D2 dopamine receptors ○ D2 antagonists - competes with dopamine to occupy binding sites. Creates elevated dopamine in the synapse. ## Footnote if psychosis is from too much DA, antipsychotics would lower it aka blocking receptors ;)
50
Positron Emission Tomography (PET):
- Detects changes in blood flow by measuring changes in uptake of compounds such as oxygen or glucose. ○ Radioactive molecules are injected into bloodstream. ○ Used to analyze metabolic activity of neurons. ○ Used to see quick changes.
51
Striatum
- Part of basal ganglia Dorsal Striatum: - Involved in habit learning, motor and action planning. Ventral Striatum: - Involved in reward learning, motivation
52
Symptoms of Schizophrenia Relate to Overstimulation of D2 Receptors:
- Most importantly location for SZ is striatum. ○ Positive symptoms need to be caused by excessive stimulation of dopamine in D2 receptors. ○ Blocking the receptors relive positive psychotic symptoms - First generation antipsychotics are not good at relieving cognitive symptoms.
53
Dopamine - SZ
- SZ could also involve under-stimulation of dopamine D1 receptors in PFC ○ Relating to cognitive impairment and disorganized nature. ○ Called hypofrontality § Explains why people with SZ struggle with planning, problem solving and high level reasoning.
54
Glutamate Hypofunction NMDA Receptor - SZ
SZ could involve reduced activity of glutamate neurons, linked to cognitive and negative symptoms.
55
GABA - SZ
- GABA balances excitatory activity from glutamate Disruptions can contribute to disorganized thinking and behaviours.
56
Synaptic Pruning - SZ
- Removal of extra synapses in adolescences can cause underlying SZ neurodevelopmental aspects. *Balance of exhibition and inhibition via NMDA receptor, lose inhibitory control of GABA
57
Stimulants - SZ
- Stimulant drugs (cocaine, amphetamines, etc) can produces psychotic symptoms in high dosages. Drugs that decrease dopamine signalling reduce psychosis.
58
Genetics - SZ
- 40% genetic heritability (strong) - Risk genes affecting neurodevelopment, immune responses, and neurotransmitter systems.
59
Dopamine Dysregulation - SZ
- Excess dopamine in subcortical regions (Striatum) is linked to positive symptoms (ie. Hallucinations, delusions). - reduced dopamine in FC contributes to cognitive deficits.
60
Glutamate and GABA imbalances:
Insufficient Glutamate activity and disrupted GABA regulation is linked to cognitive and negative symptoms. ○ Reduced motivation, emotional suppression.
61
Neurodevelopmental Factors - SZ
Excessive synaptic pruning during adolescence can lead to SZ. Environmental factors can lead to a 'two-hit' theory.
62
Mood disorder
- General emotional state or mood is distorted or inconsistent with circumstances, changed of normal - Interferes with ability to function. Types such as SAD, Bipolar Disorder, and PMDD - must be inconsistent with things happening in your life.
63
Major Depressive Disorder
- Most common mood disorder - Persistent feeling of sadness, hopelessness and a lost of interest in activities they once enjoyed. ○ Doesn't go away no matter what is happening in life. ○ No feeling of pleasure - Physical symptoms such as chronic pain, and digestive issues. Affects 1 in 6 individuals
64
MDD DSM5
- Must have 5 or more symptoms within a 2 week period with a change of functioning. 1. Persistent feelings of sadness (must be present, only one) 2. Lost of interest in activities (must be present, only one) 3. Diminished ability to think or concentrate or indecisiveness 4. Appetite or weight changes (more than 5%) 5. Fatigue or decreased energy 6. Feelings or worthlessness or excessive inappropriate guilt 7. Slowing down thoughts & physical movements 8. Recurrent thoughts of death and suicide - Symptoms cannot be due to direct physiological effects of a substance or medical condition Twice as many in females
65
Genetic causes - MDD
- First degree relatives of people with depression are 2-3 times more likely to get depression as well. - Concordance rate between identical twins is 45.6% - Concordance rates between fraternal twins is 20.2% Large genetic component
66
Brain Alterations in Depression: Monoamine Hypothesis:
- Thought to be caused by deficit in monoamine signaling ○ Monoamine NT contain one amino group and an aromatic chain with two carbons. - Deficit in signalling: ○ Limited release of NTs ○ inability to clear NTs in the synapse ○ limited receptors to bind to ○ Low affinity ○ Desensitization of NT, too much in the synapse. § Dopamine, serotonin Focus on Serotonin: - Plays role in sleep, sexual behaviour, sleeping, mood/cognition. Most nuclei is in brainstem, relays info through serotonin Evidence: - Monoamine oxidase (MAO) is an enzyme which inactivated monoamines ○ First antidepressant, had bad effects - Selective noradrenergic reuptake inhibitors (SNRI) ○ Antidepressants that block the reuptake of noradrenaline at synapse. - Selective serotonin reuptake inhibitors (SSRI) ○ Antidepressants that block the reuptake of serotonin at synapse. Bring transmitter back to normal (both)
67
SSRIS at the Synapse
- Blocks serotonin reuptake transporters ○ More activation of neuron, brain structurally adapts ○ Leads to an increase in serotonin in the synapse
68
Evidence Against monoamine hypothesis
- Little evidence that low levels of NTs cause depression. ○ Lowering levels in normal people doesn't cause it - Long lag time between treatment and reduction of symptoms ○ Takes weeks for drug to relive depression. - Doesn't work for everyone SSRIs increases risk of suicide in children and adolescents.
69
The Glucocorticoid Hypothesis of Depression:
- Stressful life events play a role in etiology in depression. ○ Life events + genetics -> depression ○ Stressors and genetics may interact to make things even worse § Stress makes us more susceptible for MDD in the future - Cortisol is the main stress hormone of the HPA axis, part of the glucocorticoid hormone family. - Suggests dysfunctional regulation of the HPA axis. Disfunction can lead to depression
70
HPA Axis Dysregulation in Depression:
- Abnormal regulation of HPA axis. Most common clinical findings within depression.
71
Hypercortisolemia:
- Elevated levels or cortisol in the blood, even during non stressful times, at any time - Chronic stress can lead to over secretion of cortisol (repeated life stress overtime) ○ 45% of adults with depression lasting more than 2 years. - Impaired negative feedback of HPA axis Brain is not able to respond to elevated blood cortisol by shutting down CRH,ATCH and cortisol.
72
HPA axis NFL
- Normally: - Cortisol binds to glucocorticoid receptors in the hippocampus to activate the NFL and shuts down the stress response. ○ Shuts down by sending signals to the brain Depression: - People with depression cannot shut down their stress response as easily. - Keep releasing cortisol ○ Increased threats, increased cortisol, disrupted glucocorticoid receptors(internalized) ○ Continued exposure to high level of cortisol further damages the hippocampus Longer someone is exposed to stress, the worse things are.
73
Depression in the Hippocampus
- DGgr thinner - decrease cell density - - Evidence to suggest that the hippocampus is damaged by chronic major depression - Neuroimaging studies have shown reductions in hippocampal volume in patients with depression Successful antidepressant treatment leads to healthier hippocampal volume. - - Antidepressants help by increasing the rate of neurogenesis in hippocampus - Neurogenesis is a process that creates new neurons, cortisol blocked by cortisol and certain cytokines. - Long term decrease in hippocampal neurogenesis could explain hippocampal shrinkage seen in depression. Links Between Estrogen and the HPA Axis: ** What is Psilocybin:** - Compound found in various species of fungi (mushrooms) ○ Different mushrooms have different properties - Inactive, but when ingested/absorbed (liver), its immediately converted to psilocin which has hallucinogenic effect. - Agonist to several serotonergic receptors, similar to serotonin - May reduce the symptoms of depression - Only needs 2 doses to feel decreased depression symptoms ○ Less dose, increased lasting effects, compared to SSRI How Does This Work: - Evidence that some non-hallucinogenic analogs can also alleviate depression. - People report the trip is also beneficial ○ Problematic since 'tripping' can lead to temporary psychosis is costly to administer. § Risk of developing schizophrenia § Expensive - Work different system - Differential effects on the serotonergic system ○ Different receptor activation ○ Different behavioural outcome - Myelin is decreased in brains of MDD patients ○ Fat repels water, less fat = more water ○ Psilocybin has been shown to increase myelin density ○ Possible mechanism to assist in restoring neurotransmission balance. 5 - HT1AR - rich: - Limbic/stress circuitry ○ Emotional processing, lead to a lack of emotions 5 - HT2AR - rich: - Increases environmental sensitivity (internalizing emotions) ○ Why they seem to last longer. Take- Home Message: - Depression is very serious and debilitating illness. - Can be treated with high success by using antidepressants and psychotherapy. - Still don’t know the whole picture. Graph shows clear downward trend - Negative correlation between hippocampal volume and number of days of untreated depression
74
Estrogen and HPA axis
- Estrogen levels vary over the menstrual cycle - Only possible to understand the stress response in females is by studying different points in the cycle. - Estrogen is protective against stress and depression. - Postpartum depression
75
What is Psilocybin:
- Compound found in various species of fungi (mushrooms) ○ Different mushrooms have different properties - Inactive, but when ingested/absorbed (liver), its immediately converted to psilocin which has hallucinogenic effect. - Agonist to several serotonergic receptors, similar to serotonin - May reduce the symptoms of depression - Only needs 2 doses to feel decreased depression symptoms ○ Less dose, increased lasting effects, compared to SSRI
76
How do Psilocybins work
- Evidence that some non-hallucinogenic analogs can also alleviate depression. - People report the trip is also beneficial ○ Problematic since 'tripping' can lead to temporary psychosis is costly to administer. § Risk of developing schizophrenia § Expensive - Work different system - Differential effects on the serotonergic system ○ Different receptor activation ○ Different behavioural outcome - Myelin is decreased in brains of MDD patients ○ Fat repels water, less fat = more water ○ Psilocybin has been shown to increase myelin density Possible mechanism to assist in restoring neurotransmission balance.
77
HT1AR and HT2AR
5 - HT1AR - rich: - Limbic/stress circuitry ○ Emotional processing, lead to a lack of emotions 5 - HT2AR - rich: - Increases environmental sensitivity (internalizing emotions) Why they seem to last longer.
78
What is Addiction?
- ' A syndrome at the centre of which is loss of control over a reward-seeking behaviour' Compulsive nature
79
What is Reward
- Stimuli that are desirable or positive in some way impacting behaviour ○ Tendency to enjoy naturally rewarding stimuli. - Humans naturally find specific activities rewarding ○ Usually critical to survival § Eating, sleeping, sex, exercise - Rewarding stimuli varies between people depending on their experience. Learned behaviours - we value more than was we were born liking.
80
Discovery of the Reward System: | olds and Milner
- Discovered intracranial self-stimulation (ICSS) ○ Rat had electrode on brain ○ Electrode controlled by lever in the cage ○ Rat could self-stimulate via pushing lever § Medial forebrain bundle ○ Rats would constantly press lever and ignore everything else § Even eating, water, females. ○ Resembled humans behaviour with drug addiction
81
# what happens when DA is released to those areas, HOW DO DRUGS IMPACT The mesocorticolimbic dopamine system | VTA, Nucleus Accumbens, Prefrontal Cortex, Hippocampus
- Begins within the midbrain in the ventral tegmental area - Neurons in the VTA project axons to regions in the limbic system and cortex. - Dopamine is main neurotransmitter - Hippocampus ○ DA released, reminds brain of positive feelings - Nucleus Accumbens ○ DA released, pleasure feeling ○ Inhibitory but breaks over time § Impacts set point ○ 'teaching signal' § Expectation and experience of a rewarding stimulus □ Unexpected rewards lead to larger dopamine release - Prefrontal Cortex ○ DA feeling, planning for future - next hit,etc - When on drugs, neuron in VTA become activated, they release dopamine into PFC, NA and Hippo - Addictive drugs lead to supraphysiological dopamine Release is much larger than what would happen naturally
82
How Do We Diagnose 'Addiction'?
- Addiction is not a diagnostic term - DSM - 5 uses 'Substance Use Disorder' - Under the DSM patient must have 2+ criteria within the past year ○ Using in spite of adverse consequences ○ Preoccupation with obtaining the drug ○ Great deal of time spent getting the drug ○ Craving ○ Use result in failure to fulfill major role obligations ○ Tolerance ○ Withdrawal Mild, moderate, or severe spectrum
83
Drug Tolerance:
- Increased amount of a drug needed to become intoxicated, or decreased effects while using the same amount of drug. ○ Can have high blood levels of drug and not seem intoxicated - Can become tolerant to some aspects of a drug but not others ○ Tolerant to different aspects at different speeds Increased HR, decreased balance
84
Drug Withdrawal:
- Acute or long term drug use can lead to withdrawal - Behavioural and physiological symptoms when someone stops taking drug ○ Opposite to drug effects ○ Severity varies based on the person and their history of drug use § Hangover § Muscle aches, cramps, anxiety, sweating, nausea, convolution, death
85
Withdrawal Effects:
1. Brain is in normal drug-free homeostasis 2. Taking drug leads to imbalance 3. Compensatory adaptations to try and restore homeostasis 4. Quitting drug leads to imbalance in opposite direction - withdrawal
86
How Common are Substance Use Disorders?
- Varies across countries, 4% of population will receive diagnosis of a substance use disorder - 87% of Canadians use substances ○ Treatment gap, people will not seek help or only those on extreme end will actually be helps by medical professionals
87
Vulnerability to Addiction:
- Addictive behaviour + vulnerable person + stress - Addiction is not the disease, it is a coping mechanism for stress / PTSD - Early life trauma is a very big predictor for later life addiction 5 times more likely to have a SUD after childhood sexual assault
88
Adverse Child Experience Scale:
- Questions about how life was as a kid, most people have two of the possible answers checked off ○ Higher amount = higher likelihood - Scale assesses negative childhood experiences (ACE) ○ ACE's are linked too § Risky health behaviours § Chronic health conditions □ Increased major mental health disorders § Increased morbidity and mortality
89
What is Cannabis
- Most used illegal drug in the world - Has medicinal properties, associated with some harm - 80 cannabionids ○ Most common tetrahydrocannabinol (THC) ○ Cannabidiol (CBD) Psychoactive not intoxicating
90
Cannabis Administration
- Inhalation ○ 50% enters lungs, almost all enters body ○ Reaches brain in 30 seconds ○ 30-60 minute peak, lasts 3-4 hours - Vaping: ○ Peak 10 minutes after - Distributed everywhere, likes fatty tissue - Oral(eating) 'edibles' ○ Absorbed from gut slowly ○ Absorption improved by adding oil ○ Onset - 1h ○ Peak - 2-3h Larger dose needed
91
Cannabis Psychological Effects
- Cognitive ○ Decreased attention, concentration (easily distracted), learning ○ Short term and long term memory impaired - Behavioural/emotional ○ Decreased movement, increased talkativeness ○ Increase anxiety, psychosis - Perceptual ○ Decreased visual, pain, and time perception
92
Cannabinoids: Pharmacodynamics: | name of ligands and receptors
- Endocannabinoid system ○ Activated in times of stress, helps regulate / return to baseline § Sense of calm, nervous system regulation ○ Endogenous ligands: § AEA - anandamide § 2-AG ○ Main receptors: § CB 1 (brain) □ AEA and TCH bind to CB 1 □ Localized across many areas of the brain □ Almost impossible to overdose as there is no receptors in breathing or HR areas of the brain § CB2 (immune system) □ 2 - AG and CBD bind to CB 1 and CB2
93
How Endocannabinoids Work:
- Binding to receptor creates production of AEA ○ Presynapse is super activated due to stress ○ Does not need to bind to membrane, acts as a retrograde inhibition ○ Acts as a breaking system - - Cb1 receptor located pre-synaptically on axon terminals - AEA and 2-AG carry information in the opposite direction - Helps calm down all the activity of stress - NFL
94
How THC Works:
- THC mimics shape of AEA(binds to CB1 receptor), exploiting mechanism - THC binds to CB 1 receptor pre-synaptically, inhibiting release of neurotransmitters - THC is agonist to CB1 receptor - Doesn't require an active synapse to bind
95
What are the Harms Associated with Cannabis Use:
- Less harmful than alcohol - Very strong links between cannabis and psychotic disorders (SZ, etc) ○ Frequent use of high-THC cannabis ○ especially young men before 16 yrs old who have variation of COMT gene § Enhanced or reduced breakdown of dopamine § Val/Vak variant Increased enzyme activity
96
Cannabis and Mental Health:
- Using cannabis products is associated with an increase risk of developing depression, ○ People who have depression are more likely to self medicate with cannabis ○ Bilateral relationship - People use cannabis to relieve their anxiety, however high dose THC can increase anxiety and paranoia - Frequent cannabis use in younger populations may be linked to suicidal thoughts and behaviours
97
Who is Using Cannabis?
- Older adults, adults, general population, youth, young adults - Post legalization ○ Older adults use more, youth is still the most - 16-24 2X more likely to use cannabis - Average age of initiation is 18.7 but starting to see it around 16 - 18% use daily - Problematic cannabis use: ○ Being male ○ Being alone ○ Using dried flower products Primary motivation being boredom, or to reduce stress
98
Mood in manic episode
- Euphoric ○ Very cheerful, 'feeling on top of the world' - People do not think there ill or need treatment because they feel so good - May change the way they dress, makeup, person appearance, etc - May have changes in perception ○ Heightened senses (smell, hearing, vision)
99
Historical Background | Bipolar
- Ancient Greeks use the term 'mania' and 'melancholia' to describe both mania and depression. ○ Used lithium salts in a bath to calm people (mood stabilizer) - In 1851, Jean-Pierre Falret published an article about what he called ' la folie circulaire' - circular insanity ○ Talks about people going from mania to depression, first documented diagnosis on bipolar disorder (1859) - Early 1900s: ○ Emil Kraepelin studied those who have periodic mania and depression. ○ Coined the term 'manic depressive psychosis' § In early editions of the DSM 'Manic Depression' ○ DSM 5: Bipolar Disorder
100
Diagnostic Features - Bipolar I
- A manic episode ○ Period of elevated, expansive or irritable mood ○ Abnormally and persistently increased goal-directed activity or energy § Lasting at least 1 week and present most of the day almost every day. - Three or more: ○ Decreased need for sleep ○ Inflated self-esteem ○ More talkative ○ Flight of ideas - racing thoughts ○ Distractibility ○ Increased in goal-directed activity ○ Excessive involvement in activities that have painful consequences (financial) - Causes impairment in social and occupational functioning ○ Cannot go to school, work, etc - Major depressive episode after manic period
101
Diagnosic Features - Bipolar II
- Period of elevated, expansive or irritable mood ○ Abnormally and persistently increased goal-directed activity or energy ○ Lasting at least 4 days in a row, most of the day, almost every day - 3 + criteria from B1 - Unequivocal change in functioning (can still go to work, class, etc) ○ Change in mood is noticeable by others Major depressive episode later 2+ weeks
102
Prevalence, Development, Course: ## Footnote bpd
- 0.6% B1 - 0.3% for B2 - Male : Female 1:1 - B1: Age onset 18 ○ 90% have other episodes - B2: age onset mid 20s ○ Begins with depressive episode Can be triggered by childbirth Rate of Cycling: - Four or more cycles in a year People can cycle multiple times a day
103
GWAS
- Figuring out what genes are causing the issue - People with a diagnosis of bipolar are compared to a control group ○ Looks through genomes for variations
104
Genetics for BPD:
- Risk of BPD with SYNE1 gene ○ Encodes for nesprin - 1 § Links nucleoskeleton to cytoskeleton Regulates chromatin organization Nesprin - 1: Makes sure nucleus is in the proper position, prevents migration
105
Neurobiological Basis of Bipolar Disorder:
- Largely unknown - Any theory must explain the cyclical nature of disease ○ Giving antidepressants can provoke mania - First drug to treat BPD is Lithium ○ Mood stabilizer - BPD is muli-system dysregulation ○ Neurotransmiter systems (DA theory) ○ Cellular signaling and survival (BNDF theory) Energy regulation (mitochondrial theory)
106
Dopamine Theory of BPD:
- Mania can be provokes in individuals who consume moderate - high doses of amphetamines ○ Elevate synaptic levels of dopamine ○ Agonist to DA system Lithium and Valproate do have action on D2/3 receptors Failure of dopamine receptor and transporter homeostasis could show underlie of BPD elevated D2/3 receptor availablity -> increased dopamine signal -> compensatory increase in dopamine transporter levels -> decreased dopamine signal ->
107
BDNF = Brain - Derived Neurotrophic Factor
- Protein involved in plasticity of the brain ○ Supports new circuits and cell growth Increased BDNF = Increases neural plasticity
108
Cellular Signalling: BNDF Theory of BPD:
Reduced BDNF in mania and depressed states, reduced plasticity ○ BNDF is reduced among patients with BPD. ## Footnote "BDNF gene, acting like a fertilizer for the brain, influencing mood, cognition"
109
Energy Regulation: Mitochondrial Theory of BPD:
- Mitochondria is responsible for multiple cellular functions ○ Energy production, cellular growth, cell resilience - If mitochondria fails, so will cell - Mitochondrial dysfunction ○ impairs brains energy supply ○ Neurons become less resilient to stress and prone to malfunction. ○ Amplify neurotransmitter imbalances ○ Impaired neural plasticity ○ Produces too much ROS § Reactive oxygen species - Nesprin 1 should hold the mitochondria in place, but is altered. - Lithium can protect the cell and prevents damage Apoptosis: Programmed cell death
110
Fear
- Immediate reaction to danger ○ Strong motivation to escape - activations SAM pathway ○ Fight or flight § HR increase § Shaking § Pupil dilation - Intake something fearful via our senses ○ Amygdala - limbic system § Threat detection § If activated it is signally that something is a threat, downstream circuit response § Learning about fearful information □ Classical conditioning - Underlays panic disorder
111
Anxiety
- Worry about something bad happening ○ Real or perceive future threats - Active amygdala - Generalized anxiety disorder - Often comorbid with depression and other mental illnesses. - Around 50% of people with one anxiety disorder also have a second one
112
Fear Response
Input - visual thalamus - visual cortex - amygdala - SAM pathway 1 Fear and anxiety overlap, hard to tell them apart
113
Panic Disorder
- Doesn't have a specific trigger but triggered by a specific stimulus. ○ Can be more than just visual, depending on stimuli the signal will go to the correct cortex. - Surges of intense fear that reaches peak in a very short time - Less than 4% of Canadians 1:2 - male, female
114
Symptoms of a panic attack
- Increased HR - Sweating - Trembling/Shaking - Shortness of breath - Nausea / Vomiting - Dizzy - Chills/heat - Numbness/tingling - Fear of dying - Must be present at least once a month for no obvious reasons
115
Panic attack in the brain
- Massive amygdala reaction ○ Overactivation, doesn't shut off. - Resembles a normal fear response but escalates, cannot shut down ○ Absence of trigger - nothing to escape - Highly heritable 48 concordance rate - COMPT gene ○ Breakdown of amines, dysregulation of dopamine in PFC ○ Too much dopamine Heightened paying attention, executive control, etc
116
Generalized Anxiety Disorder
- Worry about everything , free-floating anxiety Most common diagnoses at university
117
GAD criteria, symptoms | Adults and children
- 3 or more - Experiences on more days than not 6 months - Restlessness - Easily fatigued - Mind going black - Muscle tension - Sleep disturbance Only one is needed in children
118
Worry
- People with GAD are often consumed by worry, their mind is dominated by intrusive thoughts. Hard to overcome as people often thing that worrying will help with the future danger - control
119
Neurobiology of GAD:
- Not associated with sympathetic nervous system over-activity - 'autonomic restrictors', SNS is less responsive to stress ○ Produces less cortisol and dopamine - Increased activation of frontal lobe when responding to stressful stimuli ○ People are often more frantic, intense thought processing - constantly worrying Reduced amygdala size and function
120
Simplified Thesis: | GAD & PD
- PD is primarily fear based. ○ During panic attacks people § Decrease PFC activity § Increased limbic and SNS activity - GAD primary anxiety-based Increased PFC activity and reduced SNS activity
121
Pharmacological Treatment of Anxiety:
- Many drugs are effective in treatment, dating back thousands of years - Alcohol has been a long time favourite for stress and anxiety - High rate of comorbidity between anxiety and alcohol use disorders. - Alcohol -> Increase GABA ○ Alcohol increases anxiety baseline - Drugs that treat anxiety are called anxiolytics ○ Fast or slow acting § Fast acting is given for PD § Low acting given for GAD - Benzodiaxepines are agonists of GABA receptors ○ Increase inhibitory signalling in the brain - leading to relaxation § Xanax (alprazolam), Valium(diazepam), Ativan(lorazepam) □ High addiction potential - SSRI are also very effective for treating anxiety - Beta blockers can treat short term anxiety ○ Block B-adrenergic receptor in CNS Good for performance anxiety as they do not pass the blood brain barrier
122
Non-Pharmacological Treatment: ## Footnote anxiety
- Cognitive Behavioural Therapy ○ Focuses on challenging distorted cognitions (thoughts) and behaviours - For PD: Interoceptive Exposure ○ Patients get exposure to trigger to evoke physical sensation to learn that they are safe - Eye Movement Desensitization and Reprocessing (EMDR): ○ For people with a history of trauma. § Asked to recall memory while making eye movements. § Makes memory susceptible to change, reactivating emotions and confusing brain resulting in the separation of semantic and emotional components.
123
History of PTSD
- Had different names throughout history - Included a formal diagnostic entity in 1980 ○ Diagnostic Entity: specific symptoms, signs, criteria Included as 'Anxiety Disorder' until DSM 5.
124
Clinical Features of PTSD
- Development of symptoms following exposure of one or more traumatic events. ○ Exposure to war, threatened or actual physical assault or sexual violence - Clinical presentation varies ○ Fear/anxiety ○ Anhedonic/dysphoric ○ Arousal/reactive Dissociative or combination
125
PTSD Diagnostic Features
- Confirmed experience of trauma, either direct exposure, witness or hearing about event from close family member or friend. - Presence of intrusion symptoms (dissociative state) ○ Recurrent, involuntary, and intrusive distressing memories or dreams. ○ Dissociative reactions (flashbacks) ○ Intense prolonged psychological distress and physiological response to cues and associated with the trauma. - Persistent avoidance of stimuli associated with the event. - Negative alterations in cognitions and mood associated with event (cannot remember what happened) ○ Negative beliefs about slf, expectations ○ Feelings of detachment or estrangement from others. - Alterations in arousal and reactivity associated with traumatic event (at least 2): ○ Irritability, agree outburst ○ Reckless, self-destructive behaviours ○ Hypervigilance (alert) ○ Exaggerated startle response ○ Problems with concentration ○ Sleep disturbance *has to significantly impact psychological well-being for at least a month - Any cluster of symptoms
126
PTSD Epidemiology
- Most common forms ○ Transportation accident (35.3%) ○ Physical assault (18.5%) ○ Life-threatening illness or injury (18.4%) - Projected life time risk in Canada for PTSD is 9.2% - PTSD is more prevalent among females than males, across lifespan and length of duration. - High risk of suicidality
127
Neural Basis of PTSD - Fear Circuit
- Medial Prefrontal cortex (mPFC) appraises the threat - If it is a threat, mPFC signals to amygdala/hypothalamus Amygdala signals to hippocampus(learn context) and hypothalamus (brainstem response)
128
Neural Basis of PTSD - Traumatic Event
- Amygdala hypersensitive, over activates - Prefrontal cortex activity reduced (ineffectively inhibits amygdala), system will not shut down. ○ Contant hypervigilance, intrusion, avoidance of stimuli associated with trauma, cognitive distortions § This is adaptive at the time however it creates an environmental mismatch when the threat is gone - body cannot recognize that there is no threat.
129
Structural Anatomical Findings: PTSD
- Reduced volume of hippocampus(ventral medial PFC) ○ Hippocampus cannot use context cues in environment to signal that environment is safe § Reduced cortical capacity to inhibit fear and other negative emotional responses.
130
Gene X Enviornment Interactions PTSD
Some people naturally have a smaller hippocampus, these people are at a greater risk for developing PTSD
131
Functional Anatomical Differences: ## Footnote PTSD
- Exaggerated amygdala activation in response to trauma-related stimuli. - Traumatic event is the unconditioned stimuli which gets paired with stimuli associated with the trauma ○ odors, sounds Sound of battle + war -> combat -> fear response
132
Neurobiological Differences: | also what it is, PTSD caused by
TSD patients have enhanced activation of SAM and HPA pathways ○ Altered adrenaline, noradrenaline, and cortisol. ○ Dysregulated signaling or noradrenalin is a biomarker for PTSD What caused this: - Excessively strong adrenergic response to event ○ Adaptive short term, memory formation
133
PTSD: Pharmacological Treatment:
- Administration of propranolol(beta-receptor antagonist) can prevent the binding or noradrenaline within hours of traumatic event. Can prevent consolidation of memories.
134
PTSD: Pharmacological Treatment: | Cannabis
- People with PTSD are more likely to develop cannabis use. ○ Higher number of cannabinoid receptors & lower endocannabinoids - Smoking high levels of THC can worsen PTSD symptoms - CBD is linked to reducing consolidation of fear memory and enhanced fear extinction.
135
Pysiocybin
** What is Psilocybin:** - Compound found in various species of fungi (mushrooms) ○ Different mushrooms have different properties - Inactive, but when ingested/absorbed (liver), its immediately converted to psilocin which has hallucinogenic effect. - Agonist to several serotonergic receptors, similar to serotonin - May reduce the symptoms of depression - Only needs 2 doses to feel decreased depression symptoms ○ Less dose, increased lasting effects, compared to SSRI Take- Home Message: - Depression is very serious and debilitating illness. - Can be treated with high success by using antidepressants and psychotherapy. - Still don’t know the whole picture. Graph shows clear downward trend - Negative correlation between hippocampal volume and number of days of untreated depression
136
How does psilocybin
How Does This Work: - Evidence that some non-hallucinogenic analogs can also alleviate depression. - People report the trip is also beneficial ○ Problematic since 'tripping' can lead to temporary psychosis is costly to administer. § Risk of developing schizophrenia § Expensive - Work different system - Differential effects on the serotonergic system ○ Different receptor activation ○ Different behavioural outcome - Myelin is decreased in brains of MDD patients ○ Fat repels water, less fat = more water ○ Psilocybin has been shown to increase myelin density ○ Possible mechanism to assist in restoring neurotransmission balance. 5 - HT1AR - rich: - Limbic/stress circuitry ○ Emotional processing, lead to a lack of emotions 5 - HT2AR - rich: - Increases environmental sensitivity (internalizing emotions) ○ Why they seem to last longer.